Clinical Trial Update: Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating biomarkers and safety of dapagliflozin given with neoadjuvant therapy in patients with breast cancer, including the HER2-neg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hyperinsulinism

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Yale University | Conditions: Breast Cancer, Hyperinsulinism | Phase 1 | Status: RECRUITING